Ragon Institute of Mass General, MIT, and Harvard
Emerson Glassey is a Postdoctoral Researcher at the Ragon Institute of MGH, MIT, and Harvard since May 2021, with prior experience as a Graduate Researcher at the Massachusetts Institute of Technology from June 2014 to April 2021, where work focused on ribosomally synthesized post-translationally modified peptides (RiPPs) and the discovery of RiPP biosynthetic gene clusters using neural networks. As an Undergraduate Researcher at the University of California, Santa Cruz, contributions included developing tools for integrating datasets and conducting drug phenotypic profiling for natural product identification, along with studies on cytological profiling and passive membrane permeability. Early research experiences included investigations at Stanford University and industry internships, leading to a PhD in Biological/Biosystems Engineering from MIT and a BS in Biochemistry and Molecular Biology from UC Santa Cruz.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.